Top 10 Biopharma Takeover Targets of 2024
Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the taking.
Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the taking.
Carcinotech can generate hundreds of printed tumors from one biopsy, intensifying cancer drug screening and personalized medicine testing.
Deciphering the complex interplay between neuronal activity and mitochondrial function is pivotal in understanding brain aging, a multifaceted process marked by declines in synaptic function…
A drug with a novel mechanism protects people against the AIDS virus for 6 months. It could speed the end of the epidemic—if those who…
Clinical trial results suggest that five out of six children treated with a gene therapy for hearing loss demonstrated hearing recovery.
Personal Perspective: A future powered by connection between human minds and LLMs, promises a world in which our capacity for thought and innovation is unlocked.
GEN presents data compiled by Morningstar’s Morningstar Direct asset management platform for StockWatch of the top five performing biotech stocks of 2024, and the five…
Findings implied more generally that the effects of dietary restriction on health and lifespan may be partially non-overlapping.
Dr. Mark Hyman, Dr. Frank Lipman and Viome founder Naveen Jain discussed and debated the booming field of longevity science.
BATON ROUGE — Researchers are finding that many people who take drugs to help them lose weight are also finding that their desire for alcohol…
Four decades after his lab found odd, massive particles inside cells, Leonard Rome is still determined to figure out what “vaults” do